The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia

European Neurology

Volumn 46, Issue 1, 2001, Pages 35-38

  Fukuyama, Ryuichi ^a   Izumoto, Taneno ^a   Fushiki, Shinji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aging; Alzheimer's disease; Cerebrospinal fluid; ELISA; Glial fibrillary acidic protein

Indexed keywords

APOLIPOPROTEIN E; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL DEGENERATION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALZHEIMER DISEASE; CHILD; CHILD, PRESCHOOL; DEMENTIA; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 0034948141     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050753     Document Type: Article

References (19)

1. Patterns of gliosis in Alzheimer's disease and aging cerebrum
2. Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients
3. Paired helical filaments in astrocytes: Electron microscopy and immunohistochemistry in a case of atypical Alzheimer's disease
4. Corpora amylacea increased in Alzheimer's disease
5. Evidence for apoptotic cell death in Alzheimer's disease
6. Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome
7. A sensitive ELISA for glial fibrillary acidic protein: Application in CSF of adults
8. Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: A potential diagnostic biochemical marker
9. Topographical associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus
10. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects, and its increase in cerebrospinal fluid from patients with Alzheimer's disease
11. Age-dependent change in the level of Aβ40 and Aβ42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Aβ42 to Aβ40 level in cerebrospinal fluid from Alzheimer's disease patients
12. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the autopsies of Department of Health and Human Services task force on Alzheimer's disease
13. An immunochemical study of GFAP (glial fibrillary acidic protein) expression in the mouse central nervous system supplemented with its analysis by protein chemistry
14. Quantification of glial fibrillary acidic protein (GFAP) in human body fluids by means of ELISA employing a monoclonal antibody
15. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology
16. General and dramatic glial reaction in Alzheimer's brains
17. Apolipoprotein E mRNA in the brain of patients with Alzheimer's disease
18. Cerebrospinal fluid apolipoprotein E levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein
19. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction